Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 022730/0539 | |
| Pages: | 7 |
| | Recorded: | 05/26/2009 | | |
Attorney Dkt #: | X18508 ET AL |
Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
5
|
|
Patent #:
|
|
Issue Dt:
|
10/06/2009
|
Application #:
|
10593804
|
Filing Dt:
|
03/13/2007
|
Publication #:
|
|
Pub Dt:
|
11/15/2007
| | | | |
Title:
|
HUMAN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11018950
|
Filing Dt:
|
12/20/2004
|
Publication #:
|
|
Pub Dt:
|
05/26/2005
| | | | |
Title:
|
TREATMENT OF REFRACTORY HUMAN TUMORS WITH EPIDERMAL GROWTH FACTOR RECEPTOR ANTAGONISTS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11629415
|
Filing Dt:
|
11/14/2008
|
Publication #:
|
|
Pub Dt:
|
06/16/2011
| | | | |
Title:
|
Crystal of egfr extracellular domain and cetuximab fab fragment, and uses thereof
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12308451
|
Filing Dt:
|
12/12/2008
|
Publication #:
|
|
Pub Dt:
|
06/24/2010
| | | | |
Title:
|
Lyophilized formulations of anti-egfr antibodies
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12321948
|
Filing Dt:
|
01/26/2009
|
Publication #:
|
|
Pub Dt:
|
12/03/2009
| | | | |
Title:
|
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
|
|
Assignee
|
|
|
180 VARICK STREET |
NEW YORK, NEW YORK 10014 |
|
Correspondence name and address
|
|
ELI LILLY AND COMPANY
|
|
P. O. BOX 6288
|
|
PATENT DIVISION
|
|
INDIANAPOLIS, IN 46206-6288
|
Search Results as of:
05/30/2024 01:51 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|